Global Fetal monitoring, diagnostics and predictive tests Market Size study & Forecast, by Product (Electronic Fetal Monitoring (EFM), Uterine Contraction Monitor, Ultrasound & Ultrasonography, Fetal Electrodes, Fetal Doppler and Others) by Application (

Global Fetal monitoring, diagnostics and predictive tests Market Size study & Forecast, by Product (Electronic Fetal Monitoring (EFM), Uterine Contraction Monitor, Ultrasound & Ultrasonography, Fetal Electrodes, Fetal Doppler and Others) by Application (Antepartum Fetal Monitoring, Intrapartum Fetal Monitoring), by Portability ( Portable, Non-Portable), and Regional Analysis, 2022-2029

Global Fetal monitoring, diagnostics and predictive tests Market is valued approximately USD 11.88 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2022-2029. Fetal monitoring is the method by which medical personnel examine the fetal heartbeat and assess the baby's heart rate to keep track of the baby's level of tolerance during the contractions. Medical instruments like a handheld Doppler or computerized fetal monitor are typically used to monitor it. Occasionally, a fetoscope a device like a stethoscope is used to check on the health of the infant. The Fetal monitoring, diagnostics and predictive tests market is expanding because of factors such as increasing number of post term pregnancy and growing prevalence of cardio pulmonary diseases.

The United Nations Office for Sexual and Reproductive Health published research in October 2021 that anticipated that 140 million individuals worldwide were born in 2021. These indicates the high incidence of pregnancies in year 2021, which stimulated the demand fetal monitoring diagnostics and predictive tests. Furthermore, according to CDC statistics released in December 2021, 3.66 million babies were born in 2021, an increase of 1% from the year before. Pregnancy items are in high demand, in the United States. Similarly, according to information from the Canadian government that was released in September 2022, there were about 367,684 births in Canada in 2021, up about 2% from the year before. Along with these, for instance, the Preeclampsia Foundation predicts that over 10 million women worldwide suffer from preeclampsia each year and that preeclampsia contributes to over 2.5 million preterm births. Furthermore, Preeclampsia affected at least 1 in 7 deliveries during this time, according to the Centers for Disease Control and Prevention, and its prevalence among hospitalizations for childbirth increased from around 13% in 2017 to 16% in 2019. Thus, rising prevalence of post term birth is favouring the market growth. In addition, increase in government and non-government initiatives for maternal and fetal health and rise in awareness and willingness to invest in development of fetal monitoring is creating lucrative growth to the market. However, high Cost of Fetal monitoring, diagnostics and predictive treatment and stringent regulatory procedures may halt market growth.

The key regions considered for the Global Fetal monitoring, diagnostics and predictive tests Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence, and rising technological advancement. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
GE Healthcare
Abbott Laboratories
Ambisea Technology Corp., Ltd.
Ansh Labs Llc
Atom Medical Corp.
Aviva Systems Biology LLC
Beckman Coulter Inc.
Bionet America Inc
Demeditec Diagnostics Gmbh
Eagle Biosciences Inc.

Recent Developments in the Market:
In May 2022, GE Healthcare (US) and Pulsenmore (Israel) have signed a contract to promote the usage of Pulsenmore's home healthcare ultrasound solutions and support their efforts to win US FDA approval and commercial success.
In March 2021, CONTEC Medical Systems Co., Ltd. launched the CMS1700B Color Doppler Ultrasonic Diagnostic System in China. In addition to various sections of the belly, heart, peripheral vessels, and other body parts, it is primarily helpful for identifying conditions involving the breast, obstetrics and gynaecology, tiny organs, urology, muscle, incretion, and paediatrics.

Global Fetal monitoring, diagnostics and predictive tests Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Application, Portability, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Electronic Fetal Monitoring (EFM)
Uterine Contraction Monitor
Ultrasound & Ultrasonography
Fetal Electrodes
Fetal Doppler
Others

By Application:
Antepartum Fetal Monitoring
Intrapartum Fetal Monitoring
By Portability:
Portable
Non-Portable
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

GE Healthcare
Abbott Laboratories
Ambisea Technology Corp., Ltd.
Ansh Labs Llc
Atom Medical Corp.
Aviva Systems Biology LLC
Beckman Coulter Inc.
Bionet America Inc
Demeditec Diagnostics Gmbh
Eagle Biosciences Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.